MXK · Class II · 21 CFR 886.1850

FDA Product Code MXK: Device, Analysis, Anterior Segment

Leading manufacturers include Visia Imaging S.R.L., Intelon Optics, Inc. and Oculus Optikger?te GmbH.

23
Total
23
Cleared
198d
Avg days
1999
Since
Growing category - 3 submissions in the last 2 years vs 1 in the prior period
Review times increasing: avg 342d recently vs 176d historically

FDA 510(k) Cleared Device, Analysis, Anterior Segment Devices (Product Code MXK)

23 devices
1–23 of 23

About Product Code MXK - Regulatory Context

510(k) Submission Activity

23 total 510(k) submissions under product code MXK since 1999, with 23 receiving FDA clearance (average review time: 198 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 1 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under MXK have taken an average of 342 days to reach a decision - up from 176 days historically. Manufacturers should account for longer review timelines in current project planning.

MXK devices are reviewed by the Ophthalmic panel. Browse all Ophthalmic devices →